Recently Activated Protocols

Cancer clinical trials are research studies for developing better ways of detecting, treating, and eventually preventing cancer. By taking part in a clinical trial, you are among the first to receive new research treatments before they are widely available. Your participation in a clinical trial will influence the future direction of cancer care.

If you are interested in participating in a clinical trial, consult with your physician. Please note: clinical trials are not risk free. Patients must explore the options that are best for their individuals needs with the help of their physician.

Breast

Cancer Type: Biomarker Study
Research Base: CALGB
Protocol: CALGB 70806

CALGB 70806 - Vitamin D and Breast Cancer Biomarkers (limited to Saint Mary's Health Care only)

Physician Summary:

< Age 55; FSH < 20; Staging: Vitamin D Levels; Treatment: Vitamin D /Placebo

Cancer Type: Breast - Fatigue
Research Base: NSABP
Protocol: NSABP MA.32F

NSABP/NCIC CTC MA.32.F: Biobehavioral Mechanisms of Fatigue in Patients Treated on NCIC CTG MA.32: A Phase III Randomized Trial of Metformin Versus Placebo on Recurrence and Survival in Early Stage Breast Cancer

Physician Summary:

Companion study to CTSU MA.32. Bio-Specimen Collection and Patient Questionnaires.

Cancer Type: Node (+) or High-Risk Node (-)
Research Base: NSABP
Protocol: NSABP B-47

NSABP B-47 - A Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Alone (Six Cycles of Docetaxel Plus Cyclophosphamide or Four Cycles of Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel) to Chemotherapy Plus Trastuzumab in Women with Node-Positive or High-Risk Node-Negative HER2-Low Invasive Breast Cancer

Physician Summary:

>Age 18; Resected Node(+) or High-Risk Node(-) HER2-Low (1+ to 2+ IHC). Treatment: Chemo (Physician’s choice: TC or  AC f/b WP) Alone vs Chemo +Trastuzumab

Cancer Type: Spine Mets
Research Base: RTOG
Protocol: RTOG 0631

RTOG 0631: Phase II/III Study of Image-Guided Radiosurgery/SBRT for Localized Spine Metastasis (Spectrum Health Only)

Physician Summary:

> Age 18; Stage IV - Multisite. Treatment: Image-Guided SBRT vs External Beam RT for Localized Spine Metastasis 

Cancer Control

Cancer Type: Biomarker Study
Research Base: CALGB
Protocol: CALGB 70806

CALGB 70806 - Vitamin D and Breast Cancer Biomarkers (limited to Saint Mary's Health Care only)

Physician Summary:

< Age 55; FSH < 20; Staging: Vitamin D Levels; Treatment: Vitamin D /Placebo

Cancer Type: Breast - Fatigue
Research Base: NSABP
Protocol: NSABP MA.32F

NSABP/NCIC CTC MA.32.F: Biobehavioral Mechanisms of Fatigue in Patients Treated on NCIC CTG MA.32: A Phase III Randomized Trial of Metformin Versus Placebo on Recurrence and Survival in Early Stage Breast Cancer

Physician Summary:

Companion study to CTSU MA.32. Bio-Specimen Collection and Patient Questionnaires.

Cancer Type: Cognitive Functioning
Research Base: URCC
Protocol: URCC 10055

URCC 10055: Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy at Pre-Treatment, Post-Treatment, and at Six Month Follow-Up

Physician Summary:

Invasive Breast Cancer Stage I-IIIC or High-Grade Lymphoma; Chemo Naïve. Patient to complete three Questionnaires.

Cancer Type: Spine Mets
Research Base: RTOG
Protocol: RTOG 0631

RTOG 0631: Phase II/III Study of Image-Guided Radiosurgery/SBRT for Localized Spine Metastasis (Spectrum Health Only)

Physician Summary:

> Age 18; Stage IV - Multisite. Treatment: Image-Guided SBRT vs External Beam RT for Localized Spine Metastasis 

Gastrointestinal

Cancer Type: Adenocarcinoma
Research Base: MCCRC
Protocol: MCCRC I4T-MC-JVBT

MCCRC I4T-MC-JVBT: A Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product (IMC-1121B) versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, or Stomach

Physician Summary:

≥ Age 18; Advanced Adenocarcinoma of the Esophagus, GE Junction or Stomach. Treatment: mFOLFOX6 +/- Ramucirumab 

Cancer Type: Spine Mets
Research Base: RTOG
Protocol: RTOG 0631

RTOG 0631: Phase II/III Study of Image-Guided Radiosurgery/SBRT for Localized Spine Metastasis (Spectrum Health Only)

Physician Summary:

> Age 18; Stage IV - Multisite. Treatment: Image-Guided SBRT vs External Beam RT for Localized Spine Metastasis 

Genitourinary

Cancer Type: Adv. Transitional Cell
Research Base: CALGB
Protocol: CALGB 90601

CALGB 90601 - A Randomized Double-Blinded Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab to Gemcitabine, Cisplatin, and Placebo in Patients with Advanced Transitional Cell Carcinoma

Physician Summary:

> Age 18; Staging: Unresectable Locally Advanced or Metastatic. Treatment: Gemcitabine + Cisplatin + Bevacizumab/Placebo x6 Cycles f/b Maintenance Bevacizumab/Placebo

Cancer Type: Spine Mets
Research Base: RTOG
Protocol: RTOG 0631

RTOG 0631: Phase II/III Study of Image-Guided Radiosurgery/SBRT for Localized Spine Metastasis (Spectrum Health Only)

Physician Summary:

> Age 18; Stage IV - Multisite. Treatment: Image-Guided SBRT vs External Beam RT for Localized Spine Metastasis 

Head and Neck

Cancer Type: Head & Neck
Research Base: RTOG
Protocol: RTOG 1016

(Available at Saint Mary's Health Care and Bronson Battle Creek) RTOG 1016: Phase III Trial of Radiotherapy Plus Cetuximab Versus Chemoradiotherapy in HPV-Associated Oropharnyx Cancer

Physician Summary:

> Age 18; Staging: T1-2, N2a-3, or T3-4 any N; Must be P16 Positive. Treatment: Cisplatin or Cetuximab w/ Concurrent RT

Cancer Type: Spine Mets
Research Base: RTOG
Protocol: RTOG 0631

RTOG 0631: Phase II/III Study of Image-Guided Radiosurgery/SBRT for Localized Spine Metastasis (Spectrum Health Only)

Physician Summary:

> Age 18; Stage IV - Multisite. Treatment: Image-Guided SBRT vs External Beam RT for Localized Spine Metastasis 

Lung

Cancer Type: Spine Mets
Research Base: RTOG
Protocol: RTOG 0631

RTOG 0631: Phase II/III Study of Image-Guided Radiosurgery/SBRT for Localized Spine Metastasis (Spectrum Health Only)

Physician Summary:

> Age 18; Stage IV - Multisite. Treatment: Image-Guided SBRT vs External Beam RT for Localized Spine Metastasis 

Melanoma

Cancer Type: Resected; High Risk
Research Base: CTSU
Protocol: CTSU E1609

This study is temp closed. E1609: Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High-Dose Interferon α-2b for Resected High-risk Melanoma

Physician Summary:

> Age 18; Stage IIIB-IV. Treatment: Ipilimumab vs Interferon Alpha. All physicians must complete study specific training prior to patient enrollment

Cancer Type: Spine Mets
Research Base: RTOG
Protocol: RTOG 0631

RTOG 0631: Phase II/III Study of Image-Guided Radiosurgery/SBRT for Localized Spine Metastasis (Spectrum Health Only)

Physician Summary:

> Age 18; Stage IV - Multisite. Treatment: Image-Guided SBRT vs External Beam RT for Localized Spine Metastasis 

Sarcoma

Cancer Type: Spine Mets
Research Base: RTOG
Protocol: RTOG 0631

RTOG 0631: Phase II/III Study of Image-Guided Radiosurgery/SBRT for Localized Spine Metastasis (Spectrum Health Only)

Physician Summary:

> Age 18; Stage IV - Multisite. Treatment: Image-Guided SBRT vs External Beam RT for Localized Spine Metastasis 

Unknown Primary

Cancer Type: Spine Mets
Research Base: RTOG
Protocol: RTOG 0631

RTOG 0631: Phase II/III Study of Image-Guided Radiosurgery/SBRT for Localized Spine Metastasis (Spectrum Health Only)

Physician Summary:

> Age 18; Stage IV - Multisite. Treatment: Image-Guided SBRT vs External Beam RT for Localized Spine Metastasis